1.An FES system based on dual axis inclinometer in foot drop treatment.
Yong ZHU ; Yunjing SHANG ; Jia SONG ; Tianshuang QIU
Journal of Biomedical Engineering 2013;30(2):387-394
The foot drop functional electrical stimulation (FES) system consisting of various sensors has been widely applied to the disease of the foot drop. However, the current system is limited to the research on walking on the ground and ignores other important actions of foot in one's daily life, such as walking up and down the stairs, squatting and lying down, etc. In this work, we applied the dual axis angle sensor to the system of the foot drop FES for the first time. Such a system can not only stimulate the foot drop during normal walking, but also identify squatting, sitting, and lying down etc. and furthermore, the system can switch off automatically. In the meanwhile, it can also detect falls and other dangerous actions. The accuracy of our system can achieve 100%, 81.9%, 95.8%, 99.0% and 66.9% for normal walking, sitting-standing, walking up the stairs, walking down the stairs and squatting-standing respectively.
Adult
;
Biosensing Techniques
;
instrumentation
;
methods
;
Electric Stimulation
;
instrumentation
;
methods
;
Equipment Design
;
Female
;
Foot Deformities, Acquired
;
therapy
;
Humans
;
Male
;
Middle Aged
;
Young Adult
2.Integrated database-based Screening Cohort for Asian Nomadic descendants in China (Scan-China): Insights on prospective ethnicity-focused cancer screening
Yuelin YU ; Liying QIAO ; Jing HAN ; Weiwei WANG ; Weiwei KANG ; Yunjing ZHANG ; Shu SHANG ; Ruogu MENG ; Lin ZHUO ; Siyan ZHAN ; Yunfeng XI ; Shengfeng WANG
Epidemiology and Health 2023;45(1):e2023048-
Established in 2017, the Screening Cohort for Asian Nomadic descendants in China (Scan-China) has benefited over 180,000 members of a multi-ethnic population, particularly individuals of Mongolian descent compared with the general population (Han ethnicity), in the Inner Mongolia Autonomous Region, China. This cohort study aims to evaluate the effectiveness of cancer screening and serve as a real-world data platform for cancer studies. The 6 most prevalent cancers in China are considered—namely, breast, lung, colorectal, gastric, liver and esophageal cancer. After baseline cancer risk assessments and screening tests, both active and passive follow-up (based on the healthcare insurance database, cancer registry, the front page of hospital medical records, and death certificates) will be conducted to trace participants’ onset and progression of cancers and other prevalent chronic diseases. Scan-China has preliminarily found a disproportionately lower screening participation rate and higher incidence/mortality rates of esophageal and breast cancer among the Mongolian population than among their Han counterparts. Further research will explore the cancer burden, natural history, treatment patterns, and risk factors of the target cancers.